✦ LIBER ✦

Theoretical evaluation of antiemetic effects of 5-HT3receptor antagonists for prevention of vomiting induced by cisplatin

✍ Scribed by Nakamura, Hironori; Yokoyama, Haruko; Takayanagi, Risa; Yoshimoto, Koichi; Nakajima, Akihiro; Okuyama, Kiyoshi; Iwase, Osamu; Yamada, Yasuhiko

Book ID: 125384557
Publisher: Springer-Verlag
Year: 2014
Tongue: English
Weight: 416 KB
Volume: 40
Category: Article
ISSN: 0378-7966
DOI: 10.1007/s13318-014-0175-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5-HT3Receptor Antagonists for the Preven

5-HT3Receptor Antagonists for the Prevention of Chemotherapy-Induced Nausea and Vomiting

✍ R. Elizabeth Gregory, Professor David S. Ettinger 📂 Article 📅 1998 🏛 Springer International Publishing AG 🌐 English ⚖ 314 KB

PCN24 COST-EFFECTIVENESS ANALYSIS OF 5HT

PCN24 COST-EFFECTIVENESS ANALYSIS OF 5HT3 RECEPTOR ANTAGONISTS FOR PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING

✍ MA Ruiz; J Garrido; MS García Pulgar; C Alvarez Sanz 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

PCN4 Effect of Antiemetic Prophylaxis Ag

PCN4 Effect of Antiemetic Prophylaxis Against Chemotherapy-Induced Nausea and Vomiting with 5-HT3 Receptor Antagonists in Patients with Lymphoma

✍ Lin, S.J.; Hatoum, H.T.; Balu, S. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Antiemetic effects of AS-5370, a novel s

Antiemetic effects of AS-5370, a novel serotonin 5-HT3 receptor antagonist

✍ T. Ito; N. Yoshida; Y. Miura; H. Omoya; T. Karasawa 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 226 KB

The effects of 5-HT3 receptor antagonist

The effects of 5-HT3 receptor antagonists on cisplatin-induced emesis in the pigeon

✍ Paolo Preziosi; Massimo D'Amato; Renata Del Carmine; Maria Martire; Giacomo Pozz 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 1000 KB

GR38032F, a 5HT3receptor antagonist, in

GR38032F, a 5HT3receptor antagonist, in the prophylaxis of acute cisplatin-induced nausea and vomiting

✍ Michel Marty; Jean P. Droz; Pierre Pouillart; Bernard Paule; Nils Brion; Jacques 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 330 KB

A total of 28 patients receiving cancer chemotherapy with cisplatin-containing regimens (70-120 mg/ m 2) participated in an evaluation of the efficacy and safety of GR38032F for the prevention of acute nausea and vomiting. GR38032F, a 5HT3 receptor antagonist, was given 30 min prior to cisplatin as